Melchart D, Linde K, Fischer P, Kaesmayr J
Münchener Modell - Centre for Complementary Medicine Research, Technical University/Ludwig-Maximilians-University, Kaiserstr. 9, Munich, Germany, 80801.
Cochrane Database Syst Rev. 2000(2):CD000530. doi: 10.1002/14651858.CD000530.
Extracts of the plant Echinacea (family Compositae) are widely used in some European countries and the USA for upper respiratory tract infections.
The objective of this review was to assess the effects of preparations containing extracts of Echinacea in the prevention and treatment of the common cold.
We searched the Cochrane Acute Respiratory Infections Group and Complementary Medicine Field's trials registers, MEDLINE, EMBASE, Phytodok and reference lists of articles. We also contacted researchers and manufacturers. Date of last search: Spring 1998.
Randomised and quasi-randomised trials comparing preparations containing an extract of Echinacea compared with a placebo, no treatment, or another treatment for common colds.
At least two independent reviewers assessed trial quality and extracted data.
Sixteen trials (eight prevention trials, and eight trials on treatment of upper respiratory tract infections) with a total of 3396 participants were included. Variation in preparations investigated and methodological quality of trials precluded quantitative meta-analysis. Overall, the results suggested that some Echinacea preparations may be better than placebo.
REVIEWER'S CONCLUSIONS: The majority of the available studies report positive results. However there is not enough evidence to recommend a specific Echinacea product, or Echinacea preparations for the treatment or prevention of common colds.
紫锥菊属植物(菊科)提取物在一些欧洲国家和美国被广泛用于治疗上呼吸道感染。
本综述的目的是评估含紫锥菊提取物制剂在预防和治疗普通感冒方面的效果。
我们检索了Cochrane急性呼吸道感染组和补充医学领域的试验注册库、MEDLINE、EMBASE、Phytodok以及文章的参考文献列表。我们还联系了研究人员和制造商。最后检索日期:1998年春季。
比较含紫锥菊提取物制剂与安慰剂、不治疗或其他治疗普通感冒方法的随机和半随机试验。
至少两名独立评审员评估试验质量并提取数据。
纳入了16项试验(8项预防试验和8项治疗上呼吸道感染的试验),共有3396名参与者。所研究制剂的差异和试验的方法学质量妨碍了定量荟萃分析。总体而言,结果表明一些紫锥菊制剂可能比安慰剂更好。
大多数现有研究报告了阳性结果。然而,没有足够的证据推荐特定的紫锥菊产品或紫锥菊制剂用于治疗或预防普通感冒。